| Description |
Lung cancer is the deadliest cancer in the United States. In 2019, around 140,000 deaths occurred in the Untied States due to lung cancer. Low-dose CT screening to detect lung cancer is an effective tool for preventing these deaths, but the screening has some harms associated with it in addition to the benefits. It has been established that patients have better outcomes when information about lung cancer and low-dose CT lung cancer screening is readily available to them. This allows them to participate in effective shared decision-making (SDM) regarding the decision to be screened for lung cancer. To facilitate effective SDM, SDM tools must be accessible to patients as well as clinicians. Despite this knowledge, a comprehensive patient-facing tool for lung cancer screening shared decision making is not currently available in many settings. We intend to inform the design of a doctor-prescribed, patient-facing mobile health tool to provide patients with information about their risk for lung cancer and the lung cancer screening process. We explore the user needs, perceived usefulness, and perceived ease-of-use of a mobile-based shared decisionmaking tool for patients. Our methodology included focus groups and surveys to solicit patient's needs and assess their perception of usefulness and ease-of-use. Overall, the participants' feedback supports the further development of a tool. We found many valuable recommendations to improve the usefulness and ease-of use of a patient-facing SDM tool. The recommendations will be used to inform the next steps in the development process. Including patient perspectives (user needs) in the design of a web-based tool has the potential to empower patients in the participation of SDM and lung cancer screening, leading to better health outcomes and decreasing mortality from lung cancer in the U.S. |
